[go: up one dir, main page]

FI963218L - Mykofenolihapon 5-substituoidut johdannaiset - Google Patents

Mykofenolihapon 5-substituoidut johdannaiset Download PDF

Info

Publication number
FI963218L
FI963218L FI963218A FI963218A FI963218L FI 963218 L FI963218 L FI 963218L FI 963218 A FI963218 A FI 963218A FI 963218 A FI963218 A FI 963218A FI 963218 L FI963218 L FI 963218L
Authority
FI
Finland
Prior art keywords
substituted derivatives
mycophenolic acid
mycophenolic
acid
derivatives
Prior art date
Application number
FI963218A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963218A0 (fi
FI963218A7 (fi
Inventor
Dean R Artis
Todd R Elworthy
Ronald C Hawley
David G Loughhead
Jr David J Morgans
Peter H Nelson
Jr John W Patterson
John C Rohloff
Eric B Sjogren
David B Smith
Ann Marie Waltos
Robert J Weikert
Alicia C Garcia
Mario F Zertuche
Fidencio F Andrade
Maria T L Hernandez
Francisco X T Murra
Teresa A T Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI963218A0 publication Critical patent/FI963218A0/fi
Publication of FI963218A7 publication Critical patent/FI963218A7/fi
Publication of FI963218L publication Critical patent/FI963218L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI963218A 1994-02-18 1995-02-16 Mykofenolihapon 5-substituoidut johdannaiset FI963218L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/198,749 US5493030A (en) 1994-02-18 1994-02-18 5-substituted derivatives of mycophenolic acid
PCT/US1995/001787 WO1995022538A1 (en) 1994-02-18 1995-02-16 5-substituted derivatives of mycophenolic acid

Publications (3)

Publication Number Publication Date
FI963218A0 FI963218A0 (fi) 1996-08-16
FI963218A7 FI963218A7 (fi) 1996-10-11
FI963218L true FI963218L (fi) 1996-10-11

Family

ID=22734662

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963218A FI963218L (fi) 1994-02-18 1995-02-16 Mykofenolihapon 5-substituoidut johdannaiset

Country Status (29)

Country Link
US (2) US5493030A (is)
EP (1) EP0745073B1 (is)
JP (1) JPH09509174A (is)
CN (1) CN1141038A (is)
AT (1) ATE194608T1 (is)
AU (1) AU1875495A (is)
BR (1) BR9506819A (is)
CA (1) CA2183530A1 (is)
CO (1) CO4340734A1 (is)
DE (1) DE69517957T2 (is)
DK (1) DK0745073T3 (is)
ES (1) ES2149971T3 (is)
FI (1) FI963218L (is)
GR (1) GR3033864T3 (is)
GT (1) GT199500007A (is)
HR (1) HRP950070B1 (is)
IL (2) IL124139A (is)
IS (1) IS4264A (is)
MX (1) MX9603478A (is)
MY (1) MY112804A (is)
PE (1) PE22996A1 (is)
PH (1) PH31441A (is)
PT (1) PT745073E (is)
SI (1) SI0745073T1 (is)
SV (1) SV1995000007A (is)
TW (1) TW384288B (is)
UY (2) UY23910A1 (is)
WO (1) WO1995022538A1 (is)
ZA (1) ZA951299B (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6811998B2 (en) * 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
US7214754B2 (en) * 1999-12-13 2007-05-08 Ppg Industries Ohio, Inc. Polymerizable polyol (allyl carbonate) compositions
US7179791B2 (en) 2001-01-11 2007-02-20 Duke University Inhibiting GS-FDH to modulate NO bioactivity
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
US7427636B2 (en) * 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
CN101410120A (zh) * 2003-04-25 2009-04-15 吉里德科学公司 抗炎的膦酸酯化合物
US7452901B2 (en) * 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7470724B2 (en) * 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US20090247488A1 (en) * 2003-04-25 2009-10-01 Carina Cannizzaro Anti-inflammatory phosphonate compounds
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7407965B2 (en) * 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US20050261237A1 (en) * 2003-04-25 2005-11-24 Boojamra Constantine G Nucleoside phosphonate analogs
EP1620109A2 (en) * 2003-04-25 2006-02-01 Gilead Sciences, Inc. Kinase inhibitor phosphonate conjugates
US7429565B2 (en) 2003-04-25 2008-09-30 Gilead Sciences, Inc. Antiviral phosphonate analogs
US7432261B2 (en) * 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7300924B2 (en) * 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US20050187170A1 (en) * 2003-06-16 2005-08-25 Biocryst Pharmaceuticals, Inc. Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
WO2005023791A2 (en) * 2003-09-11 2005-03-17 Sandoz Ag Process for the production of mycophenolate mofetil
WO2005044308A1 (en) * 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
WO2005044279A1 (en) * 2003-10-24 2005-05-19 Gilead Sciences, Inc. Purine nucleoside phosphonate conjugates
US20050153990A1 (en) * 2003-12-22 2005-07-14 Watkins William J. Phosphonate substituted kinase inhibitors
MXPA06006899A (es) * 2003-12-22 2006-09-04 Gilead Sciences Inc Derivados de carbovir y abacavir 4'-sustituidos asi como compuestos relacionados con actividad antiviral de virus de inmunodeficiencia humana y virus de la hepatitis c.
BRPI0418031A (pt) * 2003-12-22 2007-04-17 Gilead Sciences Inc inibidores de quinase fosfonato-substituìdos
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
HRP20070078A2 (hr) 2004-07-27 2007-05-31 Gilead Sciences Fosfonatni analozi spojeva koji inhibiraju hiv
CA2585353A1 (en) * 2004-10-26 2006-05-04 Gilead Sciences, Inc. Phosphonate derivatives of mycophenolic acid
WO2008033466A2 (en) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions and methods for treatment of viral diseases
CN101422424B (zh) * 2007-10-31 2012-10-24 王世亮 霉酚酸类药物植入剂及其制备方法和应用
PT2307435E (pt) * 2008-07-08 2012-09-19 Gilead Sciences Inc Sais de compostos inibidores de vih
US9492426B2 (en) * 2011-09-21 2016-11-15 The Texas A&M University System Mycophenolic acid analogues as anti-tumor chemosensitizing agents
CN105271935B (zh) * 2015-11-03 2017-06-30 陶祖岐 一种生活垃圾制成的装饰板和包装箱板
US10603299B2 (en) 2016-06-02 2020-03-31 Steven Baranowitz Prevention and treatment of viral infections
CA3026241A1 (en) 2016-06-02 2017-12-07 Steven Baranowitz Prevention and treatment of viral infections
US12011429B2 (en) 2016-06-02 2024-06-18 Steven Baranowitz Prevention and treatment of viral infections
WO2019027920A1 (en) 2017-08-01 2019-02-07 Gilead Sciences, Inc. CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825571A (en) * 1971-07-31 1974-07-23 Chugai Pharmaceutical Co Ltd Mycophenolic acid derivatives
JPS5542995B2 (is) * 1972-02-24 1980-11-04
JPS5529994B2 (is) * 1972-03-02 1980-08-07
US4479005A (en) * 1982-12-16 1984-10-23 The Dow Chemical Company Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids
US4515956A (en) * 1982-12-16 1985-05-07 The Dow Chemical Company Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US5231179A (en) * 1986-01-27 1993-07-27 Sumitomo Pharmaceuticals Company, Limited Heterocyclic compounds and their production
US4727069A (en) * 1987-01-30 1988-02-23 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid, derivatives thereof and pharmaceutical compositions
US4861776A (en) * 1987-01-30 1989-08-29 Syntex (U.S.A) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
JPH0637486B2 (ja) * 1988-05-18 1994-05-18 三共株式会社 新規抗生物質フタレキシンおよびその製造法
US4940797A (en) * 1989-03-23 1990-07-10 Merck & Co., Inc. Process for synthesis of FK-506 C10-C18 intermediates
US5155228A (en) * 1989-03-23 1992-10-13 Merck & Co., Inc. FK-506 C10-C18 process intermediates
US5068345A (en) * 1989-10-30 1991-11-26 Eastman Kodak Company Oxazolidinone aldol adduct
US5247083A (en) * 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid

Also Published As

Publication number Publication date
JPH09509174A (ja) 1997-09-16
TW384288B (en) 2000-03-11
UY23910A1 (es) 1995-03-06
SV1995000007A (es) 1996-02-28
GR3033864T3 (en) 2000-10-31
FI963218A0 (fi) 1996-08-16
HRP950070A2 (en) 1997-06-30
ATE194608T1 (de) 2000-07-15
MX9603478A (es) 1997-12-31
EP0745073A1 (en) 1996-12-04
FI963218A7 (fi) 1996-10-11
DK0745073T3 (da) 2000-09-18
IL112665A0 (en) 1995-05-26
PH31441A (en) 1998-11-03
UY25262A1 (es) 2001-01-31
CO4340734A1 (es) 1996-07-30
DE69517957D1 (de) 2000-08-17
PT745073E (pt) 2000-12-29
GT199500007A (es) 1996-08-10
CA2183530A1 (en) 1995-08-24
SI0745073T1 (en) 2000-12-31
AU1875495A (en) 1995-09-04
EP0745073B1 (en) 2000-07-12
BR9506819A (pt) 1997-09-09
US5633279A (en) 1997-05-27
IS4264A (is) 1995-08-19
ES2149971T3 (es) 2000-11-16
IL124139A (en) 2000-02-29
CN1141038A (zh) 1997-01-22
PE22996A1 (es) 1996-06-04
US5493030A (en) 1996-02-20
MY112804A (en) 2001-09-29
ZA951299B (en) 1996-08-16
WO1995022538A1 (en) 1995-08-24
DE69517957T2 (de) 2001-01-25
HRP950070B1 (en) 2001-02-28
IL112665A (en) 1999-05-09

Similar Documents

Publication Publication Date Title
FI963218L (fi) Mykofenolihapon 5-substituoidut johdannaiset
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
FI973613A7 (fi) Aryylisulfonyyliaminohydroksaamihappojohdannaisia
FI950910L (fi) Rasvahappojohdannaiset
NO2007004I2 (no) Farmasoytisk akseptabelt salt av mykofenolsyre
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
NO961585L (no) Arylsulfonyl-hydroksamsyre-derivater
FI951962A7 (fi) Hydroksaamihappojohdannaiset
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
FI951579A0 (fi) Paneelimaisten osien liitosrakenne
FI950909L (fi) Rasvahappojohdannaisia
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
AR016694A1 (es) Procedimiento para la preparacion de derivados de acidos 8-metoxi-3-quinoloncarboxilicos y procedimiento de purificacion.
FI894924A7 (fi) Menetelmä 5-substituoitujen 3-furaldehydien valmistamiseksi
DE69606053D1 (de) Modifizierte fluorsulfonsäure
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
FI963220A7 (fi) 5-substituoidun mykofenolihapon 4-aminojohdannaiset
EE9700186A (et) Klavulaanhappe soolad
ID25536A (id) Metode pembuatan asam-asam 4-fenil-4-sianosikloheksanoat tersubstitusi
ATE219050T1 (de) Hydroxamsäure-derivate
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid